TELA Bio (TELA) Competitors

TELA Bio (NASDAQ:TELA) and Neuronetics (NASDAQ:STIM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability, institutional ownership and community ranking.

Do analysts recommend TELA or STIM?

TELA Bio currently has a consensus target price of $13.67, suggesting a potential upside of 187.72%. Neuronetics has a consensus target price of $8.00, suggesting a potential upside of 110.53%. Given TELA Bio's stronger consensus rating and higher probable upside, analysts clearly believe TELA Bio is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Neuronetics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Does the MarketBeat Community favor TELA or STIM?

Neuronetics received 74 more outperform votes than TELA Bio when rated by MarketBeat users. However, 71.83% of users gave TELA Bio an outperform vote while only 68.31% of users gave Neuronetics an outperform vote.

Company	Underperform	Outperform
TELA Bio	Outperform Votes 51 71.83%	Underperform Votes 20 28.17%
Neuronetics	Outperform Votes 125 68.31%	Underperform Votes 58 31.69%

Do institutionals & insiders have more ownership in TELA or STIM?

94.4% of TELA Bio shares are held by institutional investors. Comparatively, 53.6% of Neuronetics shares are held by institutional investors. 5.7% of TELA Bio shares are held by insiders. Comparatively, 7.3% of Neuronetics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Is TELA or STIM more profitable?

Neuronetics has a net margin of -42.31% compared to TELA Bio's net margin of -79.83%. Neuronetics' return on equity of -72.76% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-79.83%	-201.62%	-58.60%
Neuronetics	-42.31%	-72.76%	-29.25%

Which has more volatility and risk, TELA or STIM?

TELA Bio has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500. Comparatively, Neuronetics has a beta of 2.44, indicating that its share price is 144% more volatile than the S&P 500.

Does the media refer more to TELA or STIM?

In the previous week, TELA Bio had 3 more articles in the media than Neuronetics. MarketBeat recorded 3 mentions for TELA Bio and 0 mentions for Neuronetics. Neuronetics' average media sentiment score of 0.77 beat TELA Bio's score of 0.22 indicating that Neuronetics is being referred to more favorably in the news media.

Company	Overall Sentiment
TELA Bio	Neutral
Neuronetics	Positive

Which has stronger valuation & earnings, TELA or STIM?

Neuronetics has higher revenue and earnings than TELA Bio. Neuronetics is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$58.45M	2.00	-$46.66M	-$2.07	-2.29
Neuronetics	$71.35M	1.60	-$30.19M	-$1.07	-3.55

Summary

Neuronetics beats TELA Bio on 10 of the 18 factors compared between the two stocks.